Bayer AG opened its new Research and Innovation Center at Kendall Square in Boston-Cambridge, MA, expanding its footprint into one of the world’s most innovative pharmaceutical research and development locations. Bayer invested $140 million in the 62,100-sq.-ft. building housing a new center of precision molecular oncology research equipped with state-of-the-art laboratories and offices for the development of novel targeted cancer therapies for patients. In addition, the center comprises a newly...